AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Accounts Payable of -$5.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $2.60M, a 30.15% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$7.79M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $10.42M, a 335.21% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$8.83M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was $3.08M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was -$1.36M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$5.24M, a 449.37% decline from fiscal 2022.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was $1.50M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$5.19M 10-Q · filed 2026-08-05 | $5.23M derived: sum of 3 quarters · filed 2026-08-05 | -$3.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$7.79M 10-Q · filed 2026-05-07 | $2.63M derived: sum of 2 quarters · filed 2026-05-07 | -$6.20M derived: sum of 3 quarters · filed 2026-05-07 | -$2.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $10.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.59M derived: sum of 2 quarters · filed 2026-02-26 | $5.32M derived: sum of 3 quarters · filed 2026-08-05 | $3.08M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$8.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$5.10M derived: sum of 2 quarters · filed 2026-08-05 | -$7.34M 10-Q · filed 2025-11-10 | -$4.94M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.49M 10-Q · filed 2026-08-05 | $3.88M derived: sum of 3 quarters · filed 2026-08-05 | $853.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$2.23M 10-Q · filed 2026-05-07 | $160.00K derived: sum of 2 quarters · filed 2026-05-07 | -$2.87M derived: sum of 3 quarters · filed 2026-05-07 | $3.90M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$638.00K derived: sum of 2 quarters · filed 2026-02-26 | $6.14M derived: sum of 3 quarters · filed 2026-02-26 | -$1.36M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.74M derived: sum of 2 quarters · filed 2025-11-10 | -$3.76M 10-Q · filed 2025-11-10 | $745.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $6.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$726.00K 10-Q · filed 2025-08-07 | $3.78M derived: sum of 3 quarters · filed 2026-02-26 | $6.09M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$7.50M 10-Q · filed 2025-05-08 | -$3.00M derived: sum of 2 quarters · filed 2026-02-26 | -$687.00K derived: sum of 3 quarters · filed 2026-02-26 | -$3.73M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.81M derived: sum of 2 quarters · filed 2026-02-26 | $3.77M derived: sum of 3 quarters · filed 2026-02-26 | -$5.24M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$734.00K derived: sum of 2 quarters · filed 2024-11-07 | -$9.75M 10-Q · filed 2024-11-07 | $9.17M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$12.06M 10-Q · filed 2024-08-08 | $6.86M derived: sum of 3 quarters · filed 2024-08-08 | -$1.75M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$9.01M 10-Q · filed 2024-05-09 | $9.91M derived: sum of 2 quarters · filed 2024-05-09 | $1.29M derived: sum of 3 quarters · filed 2024-05-09 | -$154.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $18.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $10.31M derived: sum of 2 quarters · filed 2024-03-14 | $8.86M derived: sum of 3 quarters · filed 2024-03-14 | $1.50M 10-K · filed 2024-03-14 |
| 2022-09-30 | -$8.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$10.06M derived: sum of 2 quarters · filed 2023-11-08 | -$17.42M 10-Q · filed 2023-11-08 | -$14.22M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-28 | -$8.81M 10-Q · filed 2023-08-28 | -$5.61M derived: sum of 3 quarters · filed 2023-08-28 | -$19.42M derived: sum of 4 quarters · filed 2023-08-28 |
| 2022-03-31 | -$7.36M 10-Q · filed 2023-05-08 | -$4.16M derived: sum of 2 quarters · filed 2023-08-28 | -$17.97M derived: sum of 3 quarters · filed 2023-08-28 | -$14.18M derived: sum of 4 quarters · filed 2023-08-28 |
| 2021-12-31 | $3.20M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | -$10.62M derived: sum of 2 quarters · filed 2023-08-28 | -$6.82M derived: sum of 3 quarters · filed 2023-08-28 | -$11.73M 10-K/A · filed 2023-08-28 |
| 2021-09-30 | -$13.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$10.02M derived: sum of 2 quarters · filed 2022-11-03 | -$14.93M 10-Q · filed 2022-11-03 | -$14.28M derived: sum of 4 quarters · filed 2023-08-28 |
| 2021-06-30 | $3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.12M 10-Q · filed 2022-08-04 | -$470.00K derived: sum of 3 quarters · filed 2023-08-28 | $7.54M derived: sum of 4 quarters · filed 2023-08-28 |
| 2021-03-31 | -$4.91M 10-Q · filed 2022-05-09 | -$4.26M derived: sum of 2 quarters · filed 2023-08-28 | $3.75M derived: sum of 3 quarters · filed 2023-08-28 | -$21.70M derived: sum of 4 quarters · filed 2023-08-28 |
| 2020-12-31 | $650.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | $8.66M derived: sum of 2 quarters · filed 2023-08-28 | -$16.79M derived: sum of 3 quarters · filed 2023-08-28 | $3.68M 10-K/A · filed 2023-08-28 |
| 2020-09-30 | $8.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$17.44M derived: sum of 2 quarters · filed 2021-11-04 | $3.03M 10-Q · filed 2021-11-04 | -$22.04M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$25.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$4.98M 10-Q · filed 2021-08-05 | -$30.05M derived: sum of 3 quarters · filed 2022-03-01 | $16.02M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $20.47M 10-Q · filed 2021-05-10 | -$4.60M derived: sum of 2 quarters · filed 2022-03-01 | $41.47M derived: sum of 3 quarters · filed 2022-03-01 | $42.59M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$25.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $21.00M derived: sum of 2 quarters · filed 2022-03-01 | $22.12M derived: sum of 3 quarters · filed 2022-03-01 | $1.37M 10-K · filed 2022-03-01 |
| 2019-09-30 | $46.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $47.18M derived: sum of 2 quarters · filed 2020-11-05 | $26.44M 10-Q · filed 2020-11-05 | $34.47M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$19.63M 10-Q · filed 2020-08-10 | -$11.60M derived: sum of 3 quarters · filed 2021-02-25 | -$3.71M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$20.75M 10-Q · filed 2020-05-05 | -$12.71M derived: sum of 2 quarters · filed 2021-02-25 | -$4.83M derived: sum of 3 quarters · filed 2021-02-25 | -$17.91M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $15.92M derived: sum of 2 quarters · filed 2021-02-25 | $2.83M derived: sum of 3 quarters · filed 2021-02-25 | $13.72M 10-K · filed 2021-02-25 |
| 2018-09-30 | $7.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$5.20M derived: sum of 2 quarters · filed 2019-11-12 | $5.69M 10-Q · filed 2019-11-12 | $3.98M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$13.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$2.20M 10-Q · filed 2019-08-08 | -$3.91M derived: sum of 3 quarters · filed 2020-03-12 | -$5.42M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $10.88M 10-Q · filed 2019-05-09 | $9.18M derived: sum of 2 quarters · filed 2020-03-12 | $7.67M derived: sum of 3 quarters · filed 2020-03-12 | $2.80M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$3.21M derived: sum of 2 quarters · filed 2020-03-12 | -$8.09M derived: sum of 3 quarters · filed 2020-03-12 | $4.96M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$6.38M derived: sum of 2 quarters · filed 2018-11-08 | $6.67M 10-Q · filed 2018-11-08 | $196.00K derived: sum of 4 quarters · filed 2019-03-26 |
| 2017-06-30 | -$4.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $8.17M 10-Q · filed 2018-08-08 | $1.70M derived: sum of 3 quarters · filed 2019-03-26 | $5.07M derived: sum of 4 quarters · filed 2019-03-26 |
| 2017-03-31 | $13.04M 10-Q · filed 2018-05-09 | $6.57M derived: sum of 2 quarters · filed 2019-03-26 | $9.94M derived: sum of 3 quarters · filed 2019-03-26 | $12.67M derived: sum of 4 quarters · filed 2019-03-26 |
| 2016-12-31 | -$6.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$3.10M derived: sum of 2 quarters · filed 2019-03-26 | -$376.00K derived: sum of 3 quarters · filed 2019-03-26 | -$274.00K 10-K · filed 2019-03-26 |
| 2016-09-30 | $3.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $6.09M derived: sum of 2 quarters · filed 2017-11-08 | $6.20M 10-Q · filed 2017-11-08 | $3.17M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $2.83M 10-Q · filed 2017-08-08 | -$191.00K derived: sum of 3 quarters · filed 2018-03-12 | $2.67M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $102.00K 10-Q · filed 2017-05-09 | -$2.92M derived: sum of 2 quarters · filed 2018-03-12 | -$58.00K derived: sum of 3 quarters · filed 2018-03-12 | -$1.98M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$160.00K derived: sum of 2 quarters · filed 2018-03-12 | -$2.08M derived: sum of 3 quarters · filed 2018-03-12 | $231.00K 10-K · filed 2018-03-12 |
| 2015-09-30 | $2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $944.00K derived: sum of 2 quarters · filed 2016-11-09 | $3.25M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $391.00K 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $2.31M 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $1.31M 10-K · filed 2017-03-06 | |||
| 2013-12-31 | $296.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |